164 related articles for article (PubMed ID: 26957003)
21. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
22. Synchronous gynecologic cancer and the use of imaging for diagnosis.
Boaventura CS; Galvão JL; Soares GM; Bitencourt AG; Chojniak R; Bringel SL; Brot LD
Rev Assoc Med Bras (1992); 2016 Apr; 62(2):116-9. PubMed ID: 27167539
[TBL] [Abstract][Full Text] [Related]
23. Role of PET/CT in the evaluation of cervical cancer.
Jover R; Lourido D; Gonzalez C; Rojo A; Gorospe L; Alfonso JM
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S55-9. PubMed ID: 18667229
[TBL] [Abstract][Full Text] [Related]
24. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
25. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
26. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study.
Antonsen SL; Jensen LN; Loft A; Berthelsen AK; Costa J; Tabor A; Qvist I; Hansen MR; Fisker R; Andersen ES; Sperling L; Nielsen AL; Asmussen J; Høgdall E; Fagö-Olsen CL; Christensen IJ; Nedergaard L; Jochumsen K; Høgdall C
Gynecol Oncol; 2013 Feb; 128(2):300-8. PubMed ID: 23200916
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography imaging for gynecologic malignancy.
Lai CH; Yen TC; Chang TC
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):37-41. PubMed ID: 17218850
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study.
Choi HJ; Roh JW; Seo SS; Lee S; Kim JY; Kim SK; Kang KW; Lee JS; Jeong JY; Park SY
Cancer; 2006 Feb; 106(4):914-22. PubMed ID: 16411226
[TBL] [Abstract][Full Text] [Related]
29. Imaging in cervical cancer.
Follen M; Levenback CF; Iyer RB; Grigsby PW; Boss EA; Delpassand ES; Fornage BD; Fishman EK
Cancer; 2003 Nov; 98(9 Suppl):2028-38. PubMed ID: 14603539
[TBL] [Abstract][Full Text] [Related]
30. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy.
Pandit-Taskar N; Gemignani ML; Lyall A; Larson SM; Barakat RR; Abu Rustum NR
Gynecol Oncol; 2010 Apr; 117(1):59-64. PubMed ID: 20117827
[TBL] [Abstract][Full Text] [Related]
31. Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.
Roman-Jimenez G; Crevoisier RD; Leseur J; Devillers A; Ospina JD; Simon A; Terve P; Acosta O
Comput Biol Med; 2016 Apr; 71():77-85. PubMed ID: 26897070
[TBL] [Abstract][Full Text] [Related]
32. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging.
Lee SI; Atri M
Radiology; 2019 Jul; 292(1):15-24. PubMed ID: 31135294
[TBL] [Abstract][Full Text] [Related]
33. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology.
Laifer-Narin SL; Genestine WF; Okechukwu NC; Hecht EM; Newhouse JH
PET Clin; 2018 Apr; 13(2):127-141. PubMed ID: 29482746
[TBL] [Abstract][Full Text] [Related]
34. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
[TBL] [Abstract][Full Text] [Related]
36. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
37. [FDG-PET and endometrial cancer].
Kolesnikov-Gauthier H; Carpentier P
Bull Cancer; 2012 Jan; 99(1):21-8. PubMed ID: 22182739
[TBL] [Abstract][Full Text] [Related]
38. The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.
Ozcan Kara P; Kara T; Kaya B; Kara Gedik G; Sari O
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):257-60. PubMed ID: 23067527
[TBL] [Abstract][Full Text] [Related]
39. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
